SNC-102 sustained release tablet
Sponsors
Synchroneuron Inc.
Conditions
Post-Traumatic Stress DisordersPost-Traumatic Stress Disorders, Combat-relatedPosttraumatic Stress DisordersStress Disorders, Post-TraumaticTourette Syndrome
Phase 2
A Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of SNC-102 in Subjects With Tourette Syndrome
WithdrawnNCT02217007
Start: 2015-04-30End: 2016-02-29Updated: 2021-04-13
Trial of Oral SNC-102 in Subjects With Combat-Related Posttraumatic Stress Disorder
WithdrawnNCT02384369
Start: 2016-06-30End: 2017-08-31Updated: 2016-04-18